Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Vascular Dementia-2019

About Conference


About Conference

Conference Series is currently bringing “16th World Congress on Vascular Dementia and Neurodegenerative Diseases” (Vascular dementia-2019) programmed to be held during September 23-24, 2019 at Hong Kong. The conference invites all the participants across the globe to attend and share their visions and convey current developments in the field of Dementia and Neurodegenerative diseases.

The session will be organized around the theme ‘Creating better knowledge on Dementia and Neurodegenerative diseases'. We will likely convey an extraordinary program which covers the complete range of research in Dementia issue and Neurodegenerative diseases and share the ethnically diverse meetings of different treatment methodology.

Vascular dementia-2019 is a yearly meeting of Neuroscience organizations as well as Dementia committees to debate the future of the Vascular Dementia in terms of collaboration, structures and organizational development.

2019 Highlights:

200+ Participation

5+ Keynote Speakers

30+ Plenary Speakers

2+ Exhibitors

14 Innovative Educational Sessions

B2B Meetings

Target Audience:

Business ambassadors, Industrial Frontrunners, Stroke Scientists, Neuro Oncologists, CEO's and R&D Heads  from Industries, Directors, Neurologist, Neurosurgeons, Psychiatrist, Neuroscientist, Head of department, Professors and Students from Academia in the research of neurological disorders.

Exhibition:

Why exhibit?

Make sales

Debut new products

Profile your brand

Meet new business partners and suppliers

Develop key relationships

Educate healthcare, medical institutions and academia

Who you will meet?

Leaders in:

Neurology

Neurosurgery

Vascular Dementia

Dementia

Neurological Disorders

Neuro Degeneration

Cerebrovascular disorders

Spine & Spinal Disorders

Stroke

Brain Tumors & Neuro Oncology

Neuropsychiatry and Mental health

Neuropharmacology

Why to attend?

16th World Congress on Vascular Dementia and Neurodegenerative Diseases an unique of a kind gathering to unite global recognized scholastics in the field of neuroscience and neurology, Brain specialists, general wellbeing professionals, researchers, scholastic reviewers, industry specialists, researchers to trade about best in class investigation and modernizations.

Aim of this conference is inspire new ideas for treatment that will be beneficial across the spectrum of Vascular Dementia-2019

 

Session/ Tracks

Session 1: Dementia| Top Vascular Dementia conferences | Dementia Meetings

Dementia is a chronic or persistent disorder of the mental ability process caused by brain diseases or injuries marked due to personality changes, memory disorders and impaired reasoning. Dementia is not a specific disease. It's a group of symptoms related with a decline in memory or other thinking ability skills enough to reduce a person's ability activities. Various kinds of dementia are associated with particular types of brain cell damage in particular regions of the brain

Session 2: Vascular Dementia| Top Dementia conferences | Neurodegenerative Events

Vascular dementia, which occurs after a stroke, is the second most common dementia type. But there are many other conditions that can cause symptoms of dementia, including some that are reversible, such as thyroid problems and vitamin deficiencies. In vascular dementia, changes in thinking skills sometimes occur suddenly following strokes that block major brain blood vessels. Thinking problems also may begin as mild changes that worsen gradually as a result of multiple minor strokes or other conditions that affect smaller blood vessels, leading to cumulative damage. Vascular dementia symptoms can vary widely, depending on the severity of the blood vessel damage and the part of the brain affected. Memory loss may or may not be a significant symptom depending on the specific brain areas where blood flow is reduced. Symptoms may be most obvious when they happen soon after a major stroke

Session 3: Dementia stages| Neuroscience Meetings | Dementia conferences

Dementia in stages refers how far a person’s dementia has been progressed. It defines a person’s disease stage helping physicians to determine the best treatment approach and aid communication between health providers and caregivers. Sometimes the stage is simply referred to as “early stage”, “middle stage” or “late-stage” dementia, but often a more exact stage is assigned, based on a person’s symptoms.

                                                      

Session 4: Neurodegenerative Diseases | Vascular dementia conferences | Stroke conferences

Neurodegenerative disease is an umbrella term for a range of conditions which primarily affect the neurons in the human brain. Neurons are the building blocks of the nervous system which includes the brain and spinal cord. Neurons normally don’t reproduce or replace themselves, so when they become damaged or die they cannot be replaced by the body. Examples of neurodegenerative diseases include Parkinson’s, Alzheimer’s, and Huntington’s disease.

Session 5: Lewy body Dementia | Vascular dementia conferences | Neurodegenerative events

Lewy body is also known as dementia with Lewy bodies, with Lewy body dementia is the second most common type of progressive dementia after Alzheimer's disease dementia. Protein deposits, called Lewy bodies, develop in nerve cells in the brain regions involved in thinking, memory and movement (motor control).

Session 6: Amyloid Imaging in Dementia | Neurology conferences | Dementia meetings 2019

Amyloid imaging is a technique performed in nuclear medicine. It uses PET ligands that allow in vivo detection of amyloid plaques, a core pathologic feature of Alzheimer disease and dementia.

Session 7: Dementia Nursing | Neuroscience meetings 2019 | Dementia conferences

Caregivers of dementia patients need to understand dementia so that they can understand what the patient is going through. They need to know about underlying diseases, and how these may affect the progress of dementia. They also need to know what sort of behavior to expect. Understanding these helps them plan for their caregiving and to cope with the situation effectively, and with less stress.

Session 8: Treating Dementia | Top dementia conferences | Neuroscience conferences         

Treatment of dementia begins with the treatment of the underlying disease, where possible. The underlying causes of nutritional, hormonal, tumour-caused or drug-related dementia may be reversible to some extent. For many other diseases, such as Alzheimer's disease (AD), no cure has yet been discovered. However, improvement of cognitive and behavioural symptoms can be achieved through a combination of appropriate medications and other treatments, including psychotherapy.

Session 9: Animal Models in Dementia | Top vascular dementia conferences | Neurology events

The animal models of dementia and Alzheimer's disease. For pre-clinical testing and clinical translation. Dementia is a clinical syndrome with abnormal degree of memory loss and impaired ability to recall events from the past often characterized by Alzheimer's disease.

Session 10: Neuro Oncology and CNS | Neurological disorders meetings |Neuroscience conferences

It is a branch of Medical Sciences majorly deals with Neuro tumors. Deals with Studies related to Brain and Spinal cord neoplasms. Neuro-oncology and Pediatric Neuro-oncology are the two different Concepts that differentiate the determining methodology of Neuro tumors. Neuro-oncology mainly includes especially related topics like Radiation therapy, Neurosurgery, Neuroimaging, social, Psychological, Neuropathology and psychiatric aspects.

Session 11: Neuropharmacology | Stroke conferences | Dementia conferences

Neuropharmacology is the scientific study of the effects of drugs on the nervous system. Its primary focus is the actions of medications for psychiatric and neurologic disorders as well as those of drugs of abuse. Drugs that act on the nervous system, including antidepressant, antianxiety, anticonvulsant, and antipsychotic agents, are among the most widely prescribed medications.

Session 12: Vascular Cognitive Impairment | Neuroscience events | Vascular dementia conferences

Vascular cognitive impairment is a decline in thinking abilities caused by disease that damages the brain’s blood vessels. Vascular disease may cause cognitive impairment on its own, and can also contribute to impairments in thinking and behaviour in a person with another brain disease such as Alzheimer’s.

Session 13: Therapeutic Targets | Top Vascular dementia conferences 2019 | Neurodegenerative conferences

Therapeutic targets are bio molecules maybe a nucleic acid or a protein whose biological activity can be modified by a drug candidate. In some cases of Dementia, it is reported that proteins are the cause for the disease. For example the accumulation of amyloid protein in the regions of Brain acts as a major factor for the disorder, hence it can be a therapeutic target. Therapeutic targets play an important role in identifying the potential drug candidates. Hence the conference provides the discussion sessions to reveal the targets for drug design process.     

Related Conferences

5th International Conference on Neurological Disorders and Stroke on May 15-16, 2019 at Osaka, Japan

International Neuroimmunology conferences, Neurological disorder and Neurogenetics conferences September 26-27, 2018 Montreal, Canada

International Neuroscience conferences, Neuroradiology & Imaging conferences October 03-04, 2018 Osaka, Japan

World Pediatric Neurology conferences and Pediatric Surgery conferences October 01-02, 2018 Osaka, Japan

International Cannabis conferences and Medicinal Research conferences October 03-04, 2018 Osaka Japan

International Dementia conferences and Alzheimer’s Disease conferences March 25-26, 2019 Osaka, Japan

World Heart, Stroke conferences & Neurological Disorders conferences August 31-September 01, 2018 Boston, Massachusetts, USA

International Brain Disorders conferences and Therapeutics conferences September 13-15, 2018 Copenhagen, Denmark

International Neuro-Oncology Conferences and Brain Tumour Conferences September 14-15, 2018 Singapore

International Neurology: Neurochemistry conferences, Neuropharmacology conferences September 17-18, 2018 Dubai, UAE

 International Stroke conferences and Brain Haemorrhage conferences September 20-21, 2018 Prague | Czech Republic

 International Neurology Conferences and Brain Disorder Conferences September 21-22, 2018 Philadelphia, Pennsylvania, USA

Major Associations around the Globe

 

Market Analysis

16th World Congress on Vascular Dementia and Neurodegenerative Diseases is a yearly meeting of Neuroscience organizations as well as Dementia committees to debate the future of the Vascular dementia  in terms of collaboration, structures and executive development. Brain investigators, public health specialists, scientists, academic experts, Industry intellectuals, scholars to exchange about state of the art research and technologies. Intention of this conference is to inspire new ideas for treatment that will be favourable across the spectrum of  Vascular dementia -2019. Conferences, National symposiums and Workshops provide a dedicated opportunity for the advancement, implementation and exchange of information about Vascular dementia -2019 and its associated areas.

Why Hong Kong?

Hong Kong officially is the Special Administrative Region of the People's Republic of China, is a specially administered territory on the eastern side of the Pearl River estuary in southern China. With over 7.4 million people of various nationalities in a territory of 1,104 square kilometres (426 sq mi), Hong Kong is the fourth-most densely populated region in the world. Hong Kong was formerly a colony of the British Empire, after Qing China ceded Hong Kong Island at the conclusion of the First Opium War in 1842. The colony expanded to the Kowloon Peninsula in 1860 after the Second Opium War and was further extended when Britain obtained a 99-year lease of the New Territories in 1898. The entire territory was returned to China when this lease expired in 1997. As a special administrative region, Hong Kong's system of government is separate from that in mainland China Hong Kong is located east to Macao and south to China in Asia. It is the world’s seventh largest trading entity. It is also known to be Asia’s World City and is one of the major shopping destinations. There are many tourist places which are must to visit like Hong Kong Disneyland, Peak Tram, Ngong Ping, Avenue of Stars Hong Kong, Lamma Island, Sky100.

The territory features the largest number of skyscrapers in the world, most of them surrounding Victoria Harbour. Hong Kong ranks 7th on the UN Human Development Index and has the seventh-highest life expectancy in the world. Over 90% of its population makes use of well-developed public transportation, but air pollution from neighbouring industrial areas of mainland China has resulted in a high level of atmospheric particulates

Conference Highlights:

  • Dementia
  • Vascular Dementia
  • Dementia stages
  • Neurodegenerative Diseases
  • Lewy body Dementia
  • Amyloid Imaging in Dementia
  • Dementia Nursing
  • Treating Dementia
  • Animal Models in Dementia
  • Neuro Oncology and CNS
  • Neuropharmacology
  • Vascular Cognitive Impairment
  • Therapeutic Targets

Why to attend???

16th World Congress on Vascular Dementia and Neurodegenerative Diseases is a single forum to bring together worldwide eminent academics in the field of neuroscience and neurology, Brain investigators, public health experts, scientists, academic geniuses, industry researchers, scholars to exchange about state of the art research and skills.

Intention of this conference is inspire new ideas for treatment that will be helpful across the spectrum of  Vascular dementia-2019.

Unique Opportunity for Advertisers and Sponsors at this International event https://vasculardementia.neuroconferences.com/sponsors.php

UNIVERSITES IN HONG KONG

  • Li Ka Shing Faculty of Medicine
  • The Chinese University of Hong Kong C.M. Li Building for Basic Medical Science
  • The University of Hong Kong
  • Li Ping Medical Library, The Chinese University of Hong Kong
  • University Health Service, HKU
  • Li Ka Shing Institute of Health Sciences
  • The University of Hong Kong
  • Yu Chun Keung Medical Library
  • Chinese University of Hong Kong
  • CUHK-PWH Medical Centre
  • Friend Field of Beijing Medical University HK Branch
  • City University of Hong Kong
  • Hong Kong Baptist University

HOSPITALS in Hong Kong

  • hong kong stroke centre
  • Fong Ka Yeung Doctors
  • Gleneagles Hong Kong Hospital
  • Dr Pang Ka Hung Peter, Neurosurgeon, The Hong Kong Brain & Spine, Stroke & Pain Consultant Clinic
  • Hong Kong Sanatorium & Hospital
  • Hong Kong Adventist Hospital
  • Queen Mary Hospital
  • Queen Elizabeth Hospital
  • Tuen Mun Hospital
  • Hong Kong Adventist Hospital
  • Paediatric Neurology Association of Hong Kong
  • Tung Wah Hospital
  • Grantham Hospital
  • Tsan Yuk Hospital
  • The Duchess of Kent Children's Hospital at Sandy Bay

Following are the some companies in Hong Kong which yields Neurology drugs they are:

  • PharmOut Hong Kong
  • Baxter Laboratories (Hong Kong) Ltd
  • China Shineway Pharmaceutical (Hong Kong) Limited
  • Bright Future Pharmaceutical Laboratories Ltd
  • Kobayashi Pharmaceutical (Hong Kong) Company Limited
  • PharmTech (Hong Kong) Ltd
  • Advance Pharmaceutical Company Limited
  • Kwan Tak Hing Chinese Drugs Manufacturing Company
  • Zuellig Pharma Asia Pacific
  • Vita Green Headquarters
  • Bright Future Pharmaceutical Laboratories Limited.
  • Europharm Laboratoires Company Limited - Manufacturing Plant
  • Conscientia Industrial Co., Ltd Hong Kong Branch Office
  • Julius Chen & Company (HK) Limited
  • Lee's Pharmaceutical (H.K) Limited
  • Yick-Vic Chemicals & Pharmaceuticals (H.K.) Ltd

Target Audience

  • Directors
  • Head of Department
  • Professors
  • Industrial
  • Neurologist
  • Neuroscientist
  • Neuro-oncologist
  • Neuroradiologist
  • Neurosurgeons
  • Psychiatrist
  • Students from Academic circles in the research of neurology   

Member Associated with Dementia

  • Albanian Alzheimer Society
  • Chinese Dementia Research Association
  • Hong Kong Alzheimer's Disease Association
  • Alzheimer's Association
  • Dementia - World Health Organization
  • Alzheimer's Association
  • Alzheimer's Society
  • National Institute on Aging
  • National Health Council

 

 

 

 

To Collaborate Scientific Professionals around the World

Conference Date September 23-24, 2019

Speaker Opportunity

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Keytopics

  • Alzheimers Clinical Trials And Studies
  • Alzheimers Clinical Trials And Studies
  • Alzheimers Disease
  • Alzheimers Disease
  • Amnesia
  • Amnesia
  • Animal Models In Dementia
  • Animal Models In Dementia
  • Anxiety
  • Anxiety
  • Autoimmune Disorders & Multiple Sclerosis
  • Autoimmune Disorders & Multiple Sclerosis
  • Behavioral Issues
  • Behavioral Issues
  • Biopsychiatry
  • Biopsychiatry
  • Blood-Brain Barrier
  • Blood-Brain Barrier
  • Brain Diagnosis
  • Brain Diagnosis
  • Brain Disease & Failure
  • Brain Disease & Failure
  • Brain Injury
  • Brain Injury
  • Brain Tumour
  • Brain Tumour
  • Central Nervous System
  • Central Nervous System
  • Cerebrovascular Disease
  • Cerebrovascular Disease
  • Child Neurology
  • Child Neurology
  • Clinical Neurophysiology
  • Clinical Neurophysiology
  • CNS Tumors
  • CNS Tumors
  • Cognitive Disorders
  • Cognitive Disorders
  • Dementia
  • Dementia
  • Dementia Care
  • Dementia Care
  • Demyelination
  • Demyelination
  • Diagnosis And Therapy
  • Diagnosis And Therapy
  • Epilepsy
  • Epilepsy
  • Genetics
  • Genetics
  • Genetics And Epigenetics
  • Genetics And Epigenetics
  • Geriatric Neurology
  • Geriatric Neurology
  • Gut- Brain Axis
  • Gut- Brain Axis
  • Headache
  • Headache
  • Intervention Neuroradiology
  • Intervention Neuroradiology
  • Meningitis
  • Meningitis
  • Mental Health
  • Mental Health
  • Mental Health Nursing
  • Mental Health Nursing
  • Metastatis
  • Metastatis
  • Movement Disorders
  • Movement Disorders
  • Multiple Sclerosis
  • Multiple Sclerosis
  • Multiple Sclerosis Diagnosis
  • Multiple Sclerosis Diagnosis
  • Nervous System
  • Nervous System
  • Neural Engineering
  • Neural Engineering
  • Neural Enhancement
  • Neural Enhancement
  • Neuro-Oncology
  • Neuro-Oncology
  • Neuroanaatomy
  • Neuroanaatomy
  • Neuroanatomy
  • Neuroanatomy
  • Neurocritical Care
  • Neurocritical Care
  • Neurodegeneration
  • Neurodegeneration
  • Neurodegenerative Disorder
  • Neurodegenerative Disorder
  • Neurodegenerative Disorders
  • Neurodegenerative Disorders
  • Neurogenetics
  • Neurogenetics
  • Neuroimaging
  • Neuroimaging
  • Neuroimmunology
  • Neuroimmunology
  • Neurological Disorders
  • Neurological Disorders
  • Neurological Disorders And Stroke
  • Neurological Disorders And Stroke
  • Neurological Infections
  • Neurological Infections
  • Neurological Surgery
  • Neurological Surgery
  • Neurologist
  • Neurologist
  • Neurology
  • Neurology
  • Neuromedicines
  • Neuromedicines
  • Neuromuscular Medicine
  • Neuromuscular Medicine
  • Neuronal Autoantibodies
  • Neuronal Autoantibodies
  • Neuropathy
  • Neuropathy
  • Neuropeptides
  • Neuropeptides
  • Neuropharmacology
  • Neuropharmacology
  • Neuroscience
  • Neuroscience
  • Neurosurgery
  • Neurosurgery
  • Neurotoxicology
  • Neurotoxicology
  • Neurotoxins
  • Neurotoxins
  • Neurotransmission
  • Neurotransmission
  • Neurotransmitters
  • Neurotransmitters
  • Parkinson
  • Parkinson
  • Parkinsons Disease
  • Parkinsons Disease
  • Pediatric Neurology
  • Pediatric Neurology
  • Pharmacology
  • Pharmacology
  • Psychiatry
  • Psychiatry
  • Psychology
  • Psychology
  • Psychoneuroimmunology
  • Psychoneuroimmunology
  • Recent Research And Case Studies
  • Recent Research And Case Studies
  • Rehabilitation Therapy
  • Rehabilitation Therapy
  • Stem Cell Treatment For Neurological Disorders
  • Stem Cell Treatment For Neurological Disorders
  • Strokes
  • Strokes
  • Traumatic Brain Injury
  • Traumatic Brain Injury